A Monash University study of almost 400,000 people, published in the journal Cardiovascular Research , is the first to ...

Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, T2D and other metabolic diseases.

Braskem is considering expanding its ethylene cracker and polyethylene complex in the Brazilian state of Rio de Janeiro by 220,000 metric tons per year. During a call with analysts, company officials ...

A research team led by Prof. Li Yunhai from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

B7-33, a synthetic analog of the relaxin-2 hormone, has emerged as a molecule of significant interest in the scientific community. This peptide, designed to selectively activate the relaxin family ...

"We are excited to be entering into this collaboration with Synfini to accelerate drug discovery around a publicly available high-value target,” said Helena Mancebo, CEO of Multispan. "By using ...

Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome ...

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has announced the complete results from part A of the phase 1b clinical trial of TX45 in patients with group 2 pulmonary hypertension in heart failure with ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

Taste, pain, or response to stress -- nearly all essential functions in the human body are regulated by molecular switches called G protein-coupled receptors (GPCRs). Researchers have uncovered the ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...